117 related articles for article (PubMed ID: 34955485)
1. Expression of osteogenic markers after administration of selective estrogen receptor modulators during implant placement in the osteoporotic rat maxilla.
Park S; Heo HA; Kim KW; Pyo SW
J Oral Sci; 2022 Jan; 64(1):53-58. PubMed ID: 34955485
[TBL] [Abstract][Full Text] [Related]
2. Effect of Raloxifene on Bone Formation Around Implants in the Osteoporotic Rat Maxilla: Histomorphometric and Microcomputed Tomographic Analysis.
Park S; Heo HA; Min JS; Pyo SW
Int J Oral Maxillofac Implants; 2020; 35(2):249-456. PubMed ID: 32142560
[TBL] [Abstract][Full Text] [Related]
3. Effect of Raloxifene Administration on Bone Response Around Implant in the Maxilla of Osteoporotic Rats.
Heo HA; Park S; Jeon YS; Pyo SW
Implant Dent; 2019 Jun; 28(3):272-278. PubMed ID: 31124824
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
5. A SERM increasing the expression of the osteoblastogenesis and mineralization-related proteins and improving quality of bone tissue in an experimental model of osteoporosis.
Yogui FC; Momesso GAC; Faverani LP; Polo TOB; Ramalho-Ferreira G; Hassumi JS; Rossi AC; Freire AR; Prado FB; Okamoto R
J Appl Oral Sci; 2018; 26():e20170329. PubMed ID: 29742257
[TBL] [Abstract][Full Text] [Related]
6. Effect of a selective estrogen receptor modulator on bone formation in osteoporotic spine fusion using an ovariectomized rat model.
Park SB; Kim CH; Hong M; Yang HJ; Chung CK
Spine J; 2016 Jan; 16(1):72-81. PubMed ID: 26343247
[TBL] [Abstract][Full Text] [Related]
7. Effect of antiresorptive drugs in the alveolar bone healing. A histometric and immunohistochemical study in ovariectomized rats.
Ramalho-Ferreira G; Faverani LP; Momesso GAC; Luvizuto ER; de Oliveira Puttini I; Okamoto R
Clin Oral Investig; 2017 Jun; 21(5):1485-1494. PubMed ID: 27460567
[TBL] [Abstract][Full Text] [Related]
8. Raloxifene retards cartilage degradation and improves subchondral bone micro-architecture in ovariectomized rats with patella baja-induced - patellofemoral joint osteoarthritis.
Bei MJ; Tian FM; Xiao YP; Cao XH; Liu N; Zheng ZY; Dai MW; Wang WY; Song HP; Zhang L
Osteoarthritis Cartilage; 2020 Mar; 28(3):344-355. PubMed ID: 31326553
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells.
Shen HH; Yang CY; Kung CW; Chen SY; Wu HM; Cheng PY; Lam KK; Lee YM
J Biomed Sci; 2019 Aug; 26(1):62. PubMed ID: 31470850
[TBL] [Abstract][Full Text] [Related]
10. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene retards the progression of adjacent segmental intervertebral disc degeneration by inhibiting apoptosis of nucleus pulposus in ovariectomized rats.
Sun Q; Nan XY; Tian FM; Liu F; Ping SH; Zhou Z; Zhang L
J Orthop Surg Res; 2021 Jun; 16(1):368. PubMed ID: 34107971
[TBL] [Abstract][Full Text] [Related]
13. Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators.
de Araujo LF; Grozovsky R; dos Santos Pereira MJ; de Carvalho JJ; Vaisman M; Carvalho DP
Thyroid; 2010 Jan; 20(1):85-92. PubMed ID: 20017619
[TBL] [Abstract][Full Text] [Related]
14. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
[TBL] [Abstract][Full Text] [Related]
15. Serum bone formation marker correlation with improved osseointegration in osteoporotic rats treated with simvastatin.
Du Z; Chen J; Yan F; Doan N; Ivanovski S; Xiao Y
Clin Oral Implants Res; 2013 Apr; 24(4):422-7. PubMed ID: 22092686
[TBL] [Abstract][Full Text] [Related]
16. Advantage of ostarine over raloxifene and their combined treatments for muscle of estrogen-deficient rats.
Roch PJ; Noisser L; Böker KO; Hoffmann DB; Schilling AF; Sehmisch S; Komrakova M
J Endocrinol Invest; 2024 Mar; 47(3):709-720. PubMed ID: 37672168
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats.
Chung MT; Cheng PY; Lam KK; Chen SY; Ting YF; Yen MH; Lee YM
Menopause; 2010; 17(1):127-34. PubMed ID: 19745773
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene inhibits the overexpression of TGF-β1 in cartilage and regulates the metabolism of subchondral bone in rats with osteoporotic osteoarthritis.
Ping SH; Tian FM; Liu H; Sun Q; Shao LT; Lian QQ; Zhang L
Bosn J Basic Med Sci; 2021 Jun; 21(3):284-293. PubMed ID: 33259777
[TBL] [Abstract][Full Text] [Related]
19. Raloxifene enhances peri-implant bone healing in osteoporotic rats.
Ramalho-Ferreira G; Faverani LP; Prado FB; Garcia IR; Okamoto R
Int J Oral Maxillofac Surg; 2015 Jun; 44(6):798-805. PubMed ID: 25813087
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats.
Wu X; Glinn MA; Ostrowski NL; Su Y; Ni B; Cole HW; Bryant HU; Paul SM
Brain Res; 1999 Nov; 847(1):98-104. PubMed ID: 10564741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
